Results 131 to 140 of about 115,857 (253)
NFкB pathway suppression as a key driver of pacritinib response in high‐risk myelofibrosis
British Journal of Haematology, EarlyView.
R. Van Dijck +8 more
wiley +1 more source
RNA-seq analyses of Myeloproliferative Neoplasms
, 2018 <p>R ExpressionSet containing count data and clinical annotations for a series of Myeloproliferative Neoplasms subjected to RNA-seq analysis. </p ...
Ankur Chakravarthy
core +1 more source
Genetic alterations in myeloproliferative and myelodysplastic/myeloproliferative neoplasms – a practical guide to WHO-HAEM5 [PDF]
Within the World Health Organization (WHO) classification of haematopoietic neoplasms, particularly its fifth version from 2022 (WHO-HAEM5), myeloid neoplasms are not only grouped into myeloproliferative (MPN) and myelodysplastic neoplasms (MDS).
Reiter, Andreas +4 more
core +1 more source
Philadelphia-negative chronic myeloproliferative neoplasms
, 2014 Chronic myeloproliferative diseases without the Philadelphia chromosome marker (Ph-), although first described 60 years ago, only became the subject of interest after the turn of the millennium.
Xavier, Sandra Guerra +7 more
core
Cancer Medicine, Volume 15, Issue 10, October 2026.ABSTRACT The diagnostic landscape for the Philadelphia‐negative myeloproliferative neoplasms (MPNs), particularly in distinguishing Essential Thrombocythemia (ET) from Polycythemia Vera (PV), is compromised. The gold standard for diagnosing PV—measurement of red cell mass (RCM) by radioisotope dilution—has been largely abandoned, leading to widespread ...
Hans C. Hasselbalch +10 more
wiley +1 more source
What's Your Diagnosis? A Case of Extreme Thrombocytosis in a Dog
Veterinary Clinical Pathology, EarlyView.
Stephanie F. Anderson +5 more
wiley +1 more source
Clinical Case Reports, Volume 14, Issue 10, October 2026.ABSTRACT Chronic Lymphocytic Leukemia (CLL) and Chronic Myeloid Leukemia (CML) are two distinct hematological malignancies with different pathophysiologies and clinical courses. While each is relatively common in the elderly population, their simultaneous occurrence in a single patient is exceptionally rare and poses diagnostic and therapeutic ...
Mostafa Kamandi +1 more
wiley +1 more source
Risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
, 2011 Perspective article on risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative ...
CAZZOLA, MARIO, M. Cazzola
core +1 more source
What Is Your Diagnosis? Multiple Subcutaneous Lumps in a Horse
Veterinary Clinical Pathology, EarlyView.
Federica Meistro +4 more
wiley +1 more source
Clinical Case Reports, Volume 14, Issue 10, October 2026.ABSTRACT Persistent symptoms suggestive of idiopathic intracranial hypertension despite standard therapy should prompt urgent neuroimaging to exclude cerebral venous sinus thrombosis. When CVST is confirmed without an obvious provoking factor, evaluation for underlying myeloproliferative neoplasms, including JAK2‐positive essential thrombocythemia, is ...
Sarah Nafea +6 more
wiley +1 more source